As millions, including many healthcare professionals on the ”front line” continue to grapple with the mental health crisis arising from the pandemic, the need for innovative approaches to treating mental illness has never been greater. There is a substantial opportunity to improve care by strengthening the therapeutic alliance between patient and physician and closing the information and insights gap that has persisted in today’s conventional relationship. Otsuka has conducted the first-ever fully remote clinical trial for Major Depressive Disorder (MDD) and will share the company’s perspective on its commitment to the evolution of clinically validated, FDA-cleared digital health solutions.
